Brief: Gen Ilac Says It Receives First Regulatory Pharmaceutical Approval In Latin America From Mexican Health Authority
06/05/2026 16:02
May 6 (Reuters) - Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS GENIL.IS: GEN ILAC- RECEIVES FIRST REGULATORY PHARMACEUTICAL APPROVAL IN LATIN AMERICA FROM MEXICAN HEALTH AUTHORITY GEN ILAC - JANUARY 2026 APPLICATION COMPLETED IN RECORD TIME WITH NO DEFICIENCIES Source text: ID:nIKA3XfCKB Further company coverage: GENIL.IS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gen Ilac ve Saglik Urunleri Sanayi Ticaret
See all newsBrief: Gen Ilac Says It Wins Pharmaceutical Tender In Kazakhstan, Expects $1.19 Million Sales Contribution In 2027
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira